HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Bettie M Steinberg Selected Research

Recurrent respiratory papillomatosis

12/2015Poly(I:C) induces controlled release of IL-36γ from keratinocytes in the absence of cell death.
11/2012Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis.
4/2012Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.
1/2012T(H)2-like chemokine patterns correlate with disease severity in patients with recurrent respiratory papillomatosis.
6/2010Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11.
2/2010Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.
9/2008Immune dysregulation and tumor-associated gene changes in recurrent respiratory papillomatosis: a paired microarray analysis.
7/2006Four mutations in Epidermodysplasia verruciformis 1 (EVER1) gene are not contributors to susceptibility in RRP.
3/2004Polymorphism of transporter associated with antigen presentation 1 as a potential determinant for severity of disease in recurrent respiratory papillomatosis caused by human papillomavirus types 6 and 11.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Bettie M Steinberg Research Topics

Disease

14Papilloma (Papillomatosis)
12/2015 - 07/2002
10Neoplasms (Cancer)
01/2015 - 03/2003
6Infection
11/2012 - 05/2004
5Sarcoma (Soft Tissue Sarcoma)
10/2015 - 06/2009
4Neoplasm Metastasis (Metastasis)
10/2015 - 01/2011
3Rare Diseases (Rare Disease)
06/2010 - 03/2004
1Oropharyngeal Neoplasms
11/2012
1Head and Neck Neoplasms (Head and Neck Cancer)
11/2012
1Epidermodysplasia Verruciformis
07/2006
1Tracheal Diseases
02/2005
1Laryngeal Diseases
02/2005

Drug/Important Bio-Agent (IBA)

9Recurrent respiratory papillomatosisIBA
12/2015 - 03/2004
7Cyclooxygenase 2 (Cyclooxygenase-2)IBA
06/2012 - 09/2005
5celecoxib (Celebrex)FDA Link
10/2015 - 09/2005
5Phosphotransferases (Kinase)IBA
03/2007 - 07/2002
4Messenger RNA (mRNA)IBA
11/2012 - 05/2004
4Epidermal Growth Factor Receptor (EGF Receptor)IBA
11/2010 - 03/2003
2Sirolimus (Rapamycin)FDA Link
01/2011 - 06/2009
2Epidermal Growth Factor (EGF)IBA
03/2007 - 09/2005
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
09/2005 - 03/2005
2tensins (tensin)IBA
03/2005 - 07/2002
1CNI 1493IBA
01/2015
1rofecoxib (Vioxx)FDA Link
06/2012
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
06/2012
1harpin (messenger)IBA
01/2012
1NF-kappa B (NF-kB)IBA
11/2010
1GTP Phosphohydrolases (GTPases)IBA
11/2010
1p21-Activated KinasesIBA
11/2010
1Small Interfering RNA (siRNA)IBA
11/2010
1NF-kappaB inhibitor alphaIBA
11/2010
1KIR ReceptorsIBA
02/2010
170-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
06/2009
1RNA (Ribonucleic Acid)IBA
09/2008
14- (4- fluorophenyl)- 2- (4- hydroxyphenyl)- 5- (4- pyridyl)imidazoleIBA
03/2007
1Dinoprostone (PGE2)FDA Link
09/2005
1PTEN Phosphohydrolase (PTEN Phosphatase)IBA
03/2005
11-phenyl-3,3-dimethyltriazene (PDT)IBA
02/2005
1temoporfinIBA
02/2005
1Interleukin-18 (Interleukin 18)IBA
05/2004
1Interleukin-2 (IL2)IBA
05/2004
1DNA (Deoxyribonucleic Acid)IBA
03/2004
1Tyrosine (L-Tyrosine)FDA Link
03/2003
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
07/2002

Therapy/Procedure

1Heterologous Transplantation (Xenotransplantation)
01/2015
1Therapeutics
01/2015